| P50 | author | Amancio Carnero | Q56468043 |
| P2093 | author name string | F Blanco | |
| | V Moneo | |
| | C Navarro-Ranninger | |
| | A Alvarez-Valdés | |
| | A M González-Vadillo | |
| | B García-Serrelde | |
| | V Cepero | |
| P2860 | cites work | Cell cycle perturbations of platinum derivatives on two ovarian cancer cell lines | Q70691552 |
| | Synthesis and in Vitro and in Vivo Antitumor Activity of a Series of Trans Platinum Antitumor Complexes | Q71963241 |
| | In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2[E-HN=C(OMe)Me]2] | Q73118826 |
| | Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells | Q74256247 |
| | Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV) | Q74664487 |
| | Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug | Q28263389 |
| | Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors | Q29614306 |
| | Cisplatin: mode of cytotoxic action and molecular basis of resistance | Q29615385 |
| | Cell death: the significance of apoptosis | Q29617620 |
| | X-Ray structure of cytotoxic trans-[PtCl(2)(dimethylamine)(isopropylamine)]: interstrand cross-link efficiency, DNA sequence specificity, and inhibition of the B-Z transition. | Q31402705 |
| | Cisplatin | Q33871153 |
| | Clinical perspectives on platinum resistance | Q33948747 |
| | Current status of the development of trans-platinum antitumor drugs | Q33998355 |
| | Cell cycle and apoptosis | Q34045686 |
| | Cisplatin: from DNA damage to cancer chemotherapy. | Q34348474 |
| | If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells | Q34625589 |
| | DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. | Q34725611 |
| | Molecular aspects of resistance to antitumor platinum drugs. | Q34866688 |
| | New metal complexes as potential therapeutics | Q35206943 |
| | Apoptosis induced by anticancer drugs | Q35233723 |
| | Hallmarks of senescence in carcinogenesis and cancer therapy | Q35743144 |
| | Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex | Q36141013 |
| | Ligand effects on platinum binding to DNA. A comparison of DNA binding properties for cis- and trans-[PtCl2(amine)2] (amine = NH3, pyridine). | Q38315890 |
| | Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. | Q39826836 |
| | Apoptosis induction and DNA interstrand cross-link formation by cytotoxic trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2) : cross-linking between d(G) and complementary d(C) within oligonucleotide duplexes | Q40115562 |
| | Levels of p27(kip1) determine Aplidin sensitivity | Q40146329 |
| | Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death | Q40178336 |
| | Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis. | Q40814510 |
| | Apoptosis (the 1992 Frank Rose Memorial Lecture). | Q40874676 |
| | In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands | Q40907862 |
| | Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells | Q40924467 |
| | Cisplatin and DNA repair in cancer chemotherapy | Q40930064 |
| | Current status of structure-activity relationships of platinum anticancer drugs: activation of the trans geometry. | Q40993112 |
| | Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication | Q41202176 |
| | cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines | Q41254050 |
| | The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. | Q41284359 |
| | DNA damage checkpoints: implications for cancer therapy | Q41744080 |
| | Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines. | Q44215847 |
| | Synthesis, Structure, Biological Activity, and DNA Binding of Platinum(II) Complexes of the Type trans-[PtCl(2)(NH(3))L] (L = Planar Nitrogen Base). Effect of L and Cis/Trans Isomerism on Sequence Specificity and Unwinding Properties Observed in Glo | Q44884322 |
| | Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells | Q44904040 |
| | Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)]. | Q53937232 |
| | In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastoma. | Q54001672 |
| | Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action | Q54261977 |
| | The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin. | Q55474429 |
| | Extreme sensitivity to Yondelis® (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53 | Q57975487 |
| | A trans-platinum complex showing higher antitumor activity than the cis congeners | Q70661906 |
| P433 | issue | 8 | |
| P304 | page(s) | 521-530 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription | |
| P478 | volume | 9 | |